Global Facial Injectables Market Intelligence Report to 2027 – Players include AbbVie, Antares Pharma, Galderma and Novartis, among others –

DUBLIN–(BUSINESS WIRE)–The report “Facial Injectables Market Intelligence Report – Global Forecast to 2027” has been added to from offer.

The global facial injectables market is expected to reach USD 26.90 billion by 2027, from USD 14.06 billion in 2021, at a CAGR of 11.41% during the forecast period.

Market statistics:

The report provides market size analysis and forecasts for 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD and CHF. It helps organizational leaders make better decisions when currency data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year and the years from 2023 to 2027 as the forecast period.

  • The Americas Facial Injectables Market size was estimated at USD 5,224.76 million in 2021, is projected to reach USD 5,769.42 million in 2022, and is projected to grow at a CAGR of 11.32% to reach USD 9,944.48 million. USD by 2027.

  • The Asia Pacific Facial Injectables Market size was estimated at USD 3,377.41 Million in 2021, is projected to reach USD 3,747.26 Million in 2022, and is projected to grow at a CAGR of 11.49% to reach 6 USD 488.78 million by 2027.

  • The Europe, Middle East & Africa Facial Injectables Market size was estimated at USD 5,466.27 Million in 2021, is estimated to reach USD 6,055.69 Million in 2022 and is projected to grow at a CAGR of 11 .44% to reach USD 10,470.78 million by 2027.

Segmentation and market coverage:

The Facial Injectables report identifies key customer attributes to define the potential market and identify various needs in the industry. Understanding the economies and geographies of the potential customer group can help build business acumen for better strategic decision-making.

This market coverage across different industry verticals reveals the hidden truth about the strategies of players in different verticals and helps the organization decide on the target audience. This report gives you a composite view of the sub-markets coupled with comprehensive industry coverage and provides you with the right method of accounting factors such as standards and regulations, culture, to build the right hedging strategy for your market plan. market.

This research report categorizes Facial Injectables to forecast revenues and analyze trends in each of the following submarkets:


  • Anti-aging injections

    • Botulinum toxin A

    • Poly-L-lactic acid (PLLA) microparticles

  • Dermal fillers

    • Collagen fillers

    • Hyaluronic acid

    • Synthetic fillers

Final user:

  • Beauty clinics

  • Dermatology clinics

  • Dermatology research institutes

  • Hospitals


  • Americas

    • Argentina

    • Brazil

    • Canada

    • Mexico

    • United States

  • Asia Pacific

    • Australia

    • China

    • India

    • Indonesia

    • Japan

    • Malaysia

    • Philippines

    • Singapore

    • South Korea

    • Taiwan

    • Thailand

  • Europe, Middle East and Africa

    • France

    • Germany

    • Italy

    • Netherlands

    • Qatar

    • Russia

    • Saudi Arabia

    • South Africa

    • Spain

    • United Arab Emirates

    • UK

Enterprise Usability Profiles:

  • AbbVie Inc.

  • Advanced Dermatology and Cosmetic Surgery

  • Antares Pharma, Inc.

  • Bausch Health Companies Inc.

  • Becton, Dickinson and company

  • Bloomage BioTechnology Corporation Limited

  • Eisai Co., Ltd.

  • Galderma SA

  • Johnson & Johnson Services, Inc.

  • Medytox inc.

  • Merz Pharma GmbH & Co KGaA

  • Novartis AG

  • Pfizer Inc.

  • Prollenium Medical Technologies Inc.

  • Sanofi SA

  • Sinclair Pharma Group

  • Suneva Medical, Inc.

For more information about this report visit

Comments are closed.